Despite a 94% historical correlation, ADP and BLS job reports often diverge due to differing methodologies. Read more here.

Sarepta said on Monday that its late-stage study testing two gene-targeted therapies for Duchenne muscular dystrophy did not ...

Amid countless resumes and interviews, identifying individuals with the right mix of cognitive ability and communication ...

Far-from-equilibrium dynamics controls a broad range of processes in nature and technology, from celestial events to atoms.

Researchers compared HRQoL outcomes, measured by patient-reported outcomes, among frail patients with newly diagnosed MM who received Isa-VRd vs VRd alone.

Furthering the argument is the “pause” by the Canadian Securities Administrators (CSA) back in April 2025 on changing DE&I ...

USCIS described the move as a modernization effort designed to make verification more accessible to states that collect only ...

The UK government’s recently announced Digital ID aims to curb the prospect of work for illegal migrants, along with claiming ...

Sixty years ago, the Met Office embarked on a journey that would transform weather forecasting in the United Kingdom and ...

A long-running confirmatory trial of two of Sarepta Therapeutics’ Duchenne muscular dystrophy drugs has missed its main goal.

Revenues for the second quarter of fiscal 2025 were $65.9 million compared with $54.5 million for the same period of fiscal 2024. The year-over-year increase was driven by organic growth and the ...

US President Donald Trump has said he’s instructed the Defense Department to start testing nuclear weapons “on an equal basis ...